Year:  2017 2018 2019 2020 2021 2022 2023 2024 2025 

QPP Measure #410

Psoriasis: Clinical Response to Oral Systemic or Biologic Medications

Percentage of psoriasis patients receiving oral systemic or biologic therapy who meet minimal physician-or patient- reported disease activity levels. It is implied that establishment and maintenance of an established minimum level of disease control as measured by physician-and/or patient-reported outcomes will increase patient satisfaction with and adherence to treatment

Submission Methods: Claims, Registry
Measure Sets: Dermatology

The following codes apply for this QPP measure:

CPT Codes

CodeDescription
99201CPT Code
99202CPT Code
99203CPT Code
99204CPT Code
99205CPT Code
99212CPT Code
99213CPT Code
99214CPT Code
99215CPT Code
99324CPT Code
99325CPT Code
99326CPT Code
99327CPT Code
99328CPT Code
99334CPT Code
99335CPT Code
99336CPT Code
99337CPT Code
99341CPT Code
99342CPT Code
99343CPT Code
99344CPT Code
99345CPT Code
99347CPT Code
99348CPT Code
99349CPT Code
99350CPT Code

HCPCS Codes

CodeDescription
G0438Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
G9649Psoriasis assessment tool documented meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi))
G9651Psoriasis assessment tool documented not meeting any one of the specified benchmarks (e.g., (pga; 5-point or 6-point scale), body surface area (bsa), psoriasis area and severity index (pasi) and/or dermatology life quality index) (dlqi)) or psoriasis assessment tool not documented
G9764Patient has been treated with a systemic medication for psoriasis vulgaris
G9765Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi

ICD10CM Codes

CodeDescription
L40.0Psoriasis vulgaris
demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.